CRISPR/Cas patent wars have begun at the European Patent Office

Dr. James Legg,, November 23, 2015.

The battle for patents related to CRISPR/Cas9 technology is beginning to heat up.  On February 11, 2015 the first CRISPR/Cas9 European patent was granted to the Broad Institute at MIT and Harvard and by October 26 nine different groups have filed oppositions.  The fight over the CRISPR/Cas9 patents extends to the US where ~13 patents have been granted.  In both the US and Europe these disputes are based around who invented the technology first with competing claims coming from both the University of California and the Broad Institute.  With CRISPR/Cas9 technology opening up possibilities in agriculture and gene therapy this fight is set to continue for years to come.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply